Johnson & Johnson to acquire Cougar Biotechnology for $43 a share in cash, or $1 billionJohnson & Johnson says it will buy Cougar Biotechnology for about $1 billion in cash in a move to bulk up its cancer drug portfolio.New Brunswick-based J& J says it will pay $43 per share for the Los Angeles-based biopharmaceutical company, representing ...